41 %Among patients with type 1 diabetes (T1D), 41.0% cited impact on social life as a reason for insulin discontinuation.
Cameroundiabète de type 1observé 2016-2017publié 2021Advances in therapyeurope_pmcdocument de 12 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
1 754 evidences · page 67 / 71
41 %Among patients with type 1 diabetes (T1D), 41.0% cited impact on social life as a reason for insulin discontinuation.
Cameroundiabète de type 1observé 2016-2017publié 2021Advances in therapyeurope_pmcdocument de 12 observations
1,3 %HIV prevalence in the general population of the Democratic Republic of Congo was 1.3%.
CamerounVIH/sidapublié 2015International journal of STD & AIDSeurope_pmcdocument de 6 observations
13,8 %Morganella morganii accounted for 13.8% of isolated germs.
Camerounpied diabétiquepublié 2022The Pan African medical journaleurope_pmcdocument de 25 observations
54 %54% (20/37) of Plasmodium malariae infections in Mfou were mixed P. falciparum/P. malariae infections.
CamerounpaludismeHAL · Unilimdocument de 106 observations
33,7 %The age-standardized control rate for diabetes alone was 33.7% among women in a semi-urban population in Bafoussam, Cameroon.
Cameroundiabète (non précisé)observé 2012publié 2014BMC public healtheurope_pmcdocument de 24 observationsDOI 10.1186/1471-2458-14-696
91 %Ninety-one percent of the participants had type 2 diabetes.
Cameroundiabète de type 2publié 2007Diabetes research and clinical practiceeurope_pmcdocument de 5 observations
More than half of the households visited had at least one individual infected with Plasmodium parasites.
Camerounpaludismepublié 2021The Journal of infectious diseaseseurope_pmcdocument de 4 observationsDOI 10.1093/infdis/jiaa774
65 patients65 patients with sickle cell disease were potentially exposed to a total of ten undesirable RH antigens.
CameroundrépanocytoseHAL · Unilimdocument de 45 observations
35 mgAlbuminuria after exercise had a median of 35 mg and interquartile range of 23–80 mg in non-hypertensive type 2 diabetes patients.
Cameroundiabète de type 2publié 2017World journal of nephrologyeurope_pmcdocument de 7 observations
27 %The percentage of the diabetic population who had ever been told that they had diabetes had a median of 27%.
Cameroundiabète (non précisé)observé 2005-15publié 2016The lancet. Diabetes & endocrinologyeurope_pmcdocument de 10 observations
1,9 odds_ratioThere was an association between diabetes and cardiovascular diseases (OR 1.9 [95% CI: 0.8–4.9]).
Cameroundiabète (non précisé) · maladies cardiovasculairespublié 2017BMC health services researcheurope_pmcdocument de 7 observationsDOI 10.1186/s12913-017-2197-0
Co-treatment with Octreotide and Pegvisomant resulted in unchanged tumor size as measured by MRI in a 36 year-old male patient with a somatotropin and thyreotropin secreting pituitary adenoma.
Camerounsomatotropin and thyreotropin secreting pituitary adenomapublié 2006Annales d'endocrinologieeurope_pmcdocument de 3 observations
34 %According to the 2019 annual report of the NMCP, malaria prevalence in the Adamawa region was 34%.
Camerounpaludismeobservé 2019HAL · Unilimdocument de 106 observations
17 400 000 DALYsIn 2017, breast cancer caused 17.4 million DALYs in women.
Camerouncancer du seinobservé 2017publié 2019JAMA oncologyeurope_pmcdocument de 25 observationsDOI 10.1001/jamaoncol.2019.2996
5 hospitalisations_par_moisAu Cameroun, la fréquence des hospitalisations pour drépanocytose est estimée à entre 5 et 7 par mois chez les adolescents.
CameroundrépanocytoseHAL · Unilimdocument de 75 observations
3,4 %58 patients (3.4%) in the hospital group had no follow-up visit.
CamerounVIH/sidapublié 2012Journal of the International AIDS Societyeurope_pmcdocument de 39 observations
422 700 000 casesIn 2015, there were an estimated 422.7 million cases of cardiovascular disease.
Camerounmaladies cardiovasculairesobservé 2015publié 2017Journal of the American College of Cardiologyeurope_pmcdocument de 2 observations
26,1 %Age-standardised rates of death from neurological disorders decreased by 26.1% between 1990 and 2015.
Camerounneurological disordersobservé 1990–2015publié 2017The Lancet. Neurologyeurope_pmcdocument de 10 observations
97 %In 2017, the majority of cancer DALYs came from years of life lost (97%).
Camerouncancer (non précisé)observé 2017publié 2019JAMA oncologyeurope_pmcdocument de 25 observationsDOI 10.1001/jamaoncol.2019.2996
13,04 %Men had a PCR-positivity rate of 13.04%.
CamerounCOVID-19observé November 2020 to July 2021publié 2023VirusesOpenAlexdocument de 12 observationsDOI 10.3390/v15020407
68,5 %Among those testing HIV-positive, 68.5% (403) received CD4 testing.
CamerounVIH/sidapublié 2012Journal of the International AIDS Societyeurope_pmcdocument de 39 observations
Cameroon reported mpox cases belonging to both Clade I and Clade II.
CamerounClade I · Clade II · mpoxAfrica CDCdocument de 11 observations
45 %Population attributable risk indicated that up to 45% of stroke mortality could be reduced by appropriate detection and treatment of high blood pressure.
Camerounhypertension artériellepublié 2001Journal of hypertensioneurope_pmcdocument de 7 observationsDOI 10.1097/00004872-200101000-00006
2 samplesTwo plasma samples (one from a chimpanzee and one from a baboon) were positive for PARV4 by PCR.
CamerounPARV4publié 2010Journal of VirologyOpenAlexdocument de 10 observations
45 per_100000The median annual incidence of epilepsy in high-income countries is estimated at 45.0 per 100,000.
CamerounépilepsieHAL · Unilimdocument de 53 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.